See more : Shine Justice Ltd (SHJ.AX) Income Statement Analysis – Financial Results
Complete financial analysis of SWK Holdings Corporation (SWKH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SWK Holdings Corporation, a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- Thomson Reuters Corporation (TRI.TO) Income Statement Analysis – Financial Results
- Plasto-Cargal Group Ltd (PLCR.TA) Income Statement Analysis – Financial Results
- Asahi Kasei Corporation (AHKSF) Income Statement Analysis – Financial Results
- Indiabulls Real Estate Limited (IBREALEST.NS) Income Statement Analysis – Financial Results
- Helical plc (HLCL.L) Income Statement Analysis – Financial Results
SWK Holdings Corporation (SWKH)
About SWK Holdings Corporation
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.76M | 41.48M | 56.16M | 36.71M | 30.75M | 25.99M | 37.49M | 22.38M | 23.46M | 17.40M | 6.45M | 637.00K | 0.00 | 0.00 | 45.26M | 65.22M | 60.79M | 54.03M | 43.13M | 48.90M | 61.01M | 79.09M | 86.87M | 119.25M | 14.10M | 2.00M |
| Cost of Revenue | 3.44M | 6.95M | 7.35M | 4.27M | 1.18M | 0.00 | 0.00 | 0.00 | 10.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.54M | 20.69M | 17.24M | 12.90M | 11.74M | 11.94M | 12.83M | 32.65M | 50.61M | 50.05M | 5.40M | 400.00K |
| Gross Profit | 34.32M | 34.53M | 48.81M | 32.44M | 29.57M | 25.99M | 37.49M | 22.38M | 23.45M | 17.40M | 6.45M | 637.00K | 0.00 | 0.00 | 28.72M | 44.53M | 43.55M | 41.13M | 31.39M | 36.96M | 48.18M | 46.44M | 36.26M | 69.20M | 8.70M | 1.60M |
| Gross Profit Ratio | 90.90% | 83.24% | 86.92% | 88.37% | 96.18% | 100.00% | 100.00% | 100.00% | 99.96% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 63.45% | 68.28% | 71.64% | 76.13% | 72.78% | 75.59% | 78.97% | 58.72% | 41.74% | 58.03% | 61.70% | 80.00% |
| Research & Development | 0.00 | 6.95M | 7.35M | 4.27M | 1.18M | 0.24 | 0.88 | 0.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.85M | 13.82M | 12.65M | 10.77M | 13.23M | 19.50M | 21.44M | 25.93M | 35.56M | 42.72M | 12.90M | 2.30M |
| General & Administrative | 11.23M | 12.96M | 13.62M | 10.55M | 7.43M | 4.88M | 4.10M | 2.83M | 3.38M | 3.28M | 1.75M | 2.24M | 1.55M | 1.76M | 8.70M | 10.57M | 0.00 | 0.00 | 11.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.19M | 22.30M | 0.00 | 0.00 | 17.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.23M | 12.96M | 13.62M | 10.55M | 7.43M | 4.88M | 4.10M | 2.83M | 3.38M | 3.28M | 1.75M | 2.24M | 1.55M | 1.76M | 17.89M | 32.87M | 37.16M | 29.80M | 29.09M | 33.24M | 38.26M | 50.48M | 90.85M | 107.13M | 26.20M | 4.50M |
| Other Expenses | 8.44M | -862.00K | 4.06M | 12.09M | 7.16M | 6.18M | -5.22M | 1.66M | 10.85M | -129.00K | -60.00K | 0.00 | 0.00 | 0.00 | 5.06M | 500.00K | 288.00K | 133.00K | 6.46M | 2.41M | 7.32M | 76.42M | 746.99M | 896.75M | 82.00M | 1.50M |
| Operating Expenses | 19.67M | 19.05M | 17.68M | 22.64M | 14.59M | 11.06M | 4.10M | 4.49M | 14.23M | 3.28M | 1.75M | 2.24M | 1.55M | 1.76M | 35.79M | 47.19M | 50.10M | 40.70M | 48.78M | 55.15M | 67.02M | 152.83M | 873.39M | 1.05B | 121.10M | 8.30M |
| Cost & Expenses | 19.35M | 26.01M | 25.03M | 26.91M | 15.77M | 11.06M | 4.10M | 4.49M | 14.23M | 3.28M | 1.75M | 2.24M | 1.55M | 1.76M | 52.33M | 67.88M | 67.34M | 53.60M | 60.52M | 67.08M | 79.85M | 185.48M | 924.00M | 1.10B | 126.50M | 8.70M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.84M | 17.53M | 10.00K | 49.00K | 158.00K | 254.00K | 275.00K | 7.00K | 27.00K | 87.00K | 172.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.85M | 340.00K | 374.00K | 455.00K | 338.00K | 160.00K | 0.00 | 0.00 | 381.00K | 589.00K | 68.00K | 158.00K | 254.00K | 275.00K | 978.00K | 369.00K | 858.00K | 207.00K | 88.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.91M | 26.12M | 22.92M | 28.08M | 14.10M | 11.61M | 5.22M | 3.90M | 10.00K | 3.00K | 2.00K | 5.00K | 2.00K | 275.00K | 1.69M | 1.78M | 1.30M | 1.59M | 2.46M | 6.82M | 15.41M | 30.55M | 153.61M | 896.75M | 82.00M | 1.50M |
| EBITDA | 19.04M | 12.43M | 37.45M | 21.90M | 19.93M | 13.89M | 42.77M | 17.89M | -326.00K | 7.95M | 4.44M | -1.60M | -1.55M | -177.00K | 1.69M | -1.51M | -5.25M | 1.59M | -17.86M | -12.59M | -9.30M | -75.84M | -683.52M | -2.17B | -30.60M | -11.00M |
| EBITDA Ratio | 50.42% | 44.13% | 62.66% | 59.65% | 64.83% | 53.46% | 114.09% | 79.95% | 39.40% | 81.25% | 71.88% | -250.86% | 0.00% | 0.00% | -11.88% | -1.31% | -7.75% | 8.55% | -19.07% | -14.37% | -2.32% | -33.94% | 25.20% | 1,687.94% | -170.92% | -270.00% |
| Operating Income | 14.65M | 15.48M | 31.13M | 9.81M | 14.98M | 14.93M | 33.39M | 17.89M | 2.60M | 14.13M | 4.70M | -1.60M | -1.55M | -1.76M | -8.42M | -3.24M | -7.12M | -271.00K | -17.86M | -21.58M | -20.55M | -101.31M | -939.62M | -977.40M | -112.40M | -6.70M |
| Operating Income Ratio | 38.80% | 37.31% | 55.43% | 26.71% | 48.71% | 57.44% | 89.06% | 79.95% | 11.07% | 81.18% | 72.90% | -251.65% | 0.00% | 0.00% | -18.60% | -4.97% | -11.70% | -0.50% | -41.41% | -44.13% | -33.68% | -128.09% | -1,081.64% | -819.64% | -797.16% | -335.00% |
| Total Other Income/Expenses | -37.00K | -477.00K | 1.88M | -22.05M | -3.93M | -673.00K | -9.38M | -7.49M | -3.69M | -824.00K | -209.00K | 158.00K | 453.00K | 1.03M | 43.31M | -411.00K | -739.00K | -1.94M | 88.00K | 128.00K | -314.00K | 913.00K | -705.42M | -2.09B | -6.30M | 6.40M |
| Income Before Tax | 14.61M | 9.49M | 33.01M | 3.67M | 16.84M | 6.24M | 24.00M | 10.40M | -1.09M | 13.30M | 4.49M | -1.45M | -1.09M | -727.00K | 34.90M | -3.65M | -7.85M | -2.21M | -17.77M | -21.45M | -20.86M | -150.31M | -1.65B | -3.07B | -118.70M | -6.50M |
| Income Before Tax Ratio | 38.70% | 22.88% | 58.79% | 9.98% | 54.78% | 24.00% | 64.03% | 46.48% | -4.65% | 76.44% | 69.66% | -226.84% | 0.00% | 0.00% | 77.10% | -5.60% | -12.92% | -4.08% | -41.20% | -43.87% | -34.19% | -190.04% | -1,893.68% | -2,575.22% | -841.84% | -325.00% |
| Income Tax Expense | -1.27M | -4.00M | 7.08M | -1.54M | -6.99M | 42.00K | 15.75M | -21.64M | 3.27M | -10.30M | -9.84M | -24.00K | -26.00K | -20.00K | 3.00K | 5.00K | 167.00K | 219.00K | 196.00K | 314.00K | 318.00K | -10.28M | 105.76M | 2.09B | 6.40M | -400.00K |
| Net Income | 15.89M | 13.49M | 25.93M | 5.20M | 23.83M | 6.20M | 3.05M | 28.89M | -7.37M | 20.77M | 12.86M | -1.42M | -1.07M | -707.00K | 34.89M | -3.66M | -8.02M | -2.43M | -17.97M | -21.77M | -20.97M | -96.11M | -942.90M | -3.07B | -118.80M | -6.30M |
| Net Income Ratio | 42.07% | 32.52% | 46.17% | 14.17% | 77.50% | 23.84% | 8.13% | 129.08% | -31.42% | 119.34% | 199.50% | -223.08% | 0.00% | 0.00% | 77.10% | -5.60% | -13.19% | -4.49% | -41.66% | -44.52% | -34.37% | -121.52% | -1,085.41% | -2,575.22% | -842.55% | -315.00% |
| EPS | 1.26 | 1.05 | 2.03 | 0.40 | 1.85 | 0.47 | 0.23 | 2.22 | -0.57 | 3.20 | 3.10 | -0.34 | -0.26 | -0.17 | 8.50 | -0.89 | -2.16 | -0.70 | -5.83 | -7.52 | -8.72 | -42.90 | -686.09 | -3.96K | -773.72 | -100.67 |
| EPS Diluted | 1.25 | 1.05 | 2.02 | 0.40 | 1.85 | 0.47 | 0.23 | 2.22 | -0.57 | 3.20 | 3.10 | -0.34 | -0.26 | -0.17 | 8.50 | -0.89 | -2.16 | -0.70 | -5.83 | -7.52 | -8.72 | -42.90 | -686.09 | -3.96K | -773.72 | -100.67 |
| Weighted Avg Shares Out | 12.65M | 12.84M | 12.80M | 12.85M | 12.91M | 13.05M | 13.04M | 13.02M | 12.93M | 6.49M | 4.13M | 4.12M | 4.12M | 4.12M | 4.12M | 4.12M | 3.71M | 3.46M | 3.08M | 2.90M | 2.40M | 2.24M | 1.37M | 776.10K | 153.54K | 62.58K |
| Weighted Avg Shares Out (Dil) | 12.70M | 12.88M | 12.83M | 12.86M | 12.91M | 13.05M | 13.04M | 13.02M | 12.99M | 6.49M | 4.14M | 4.12M | 4.12M | 4.12M | 4.12M | 4.12M | 3.71M | 3.46M | 3.08M | 2.90M | 2.40M | 2.24M | 1.37M | 776.10K | 153.54K | 62.58K |
SWK Holdings' Subsidiary, Enteris BioPharma, Receives Second Milestone Payment from Cara Therapeutics
DALLAS, Dec. 24, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned subsidiary, Enteris BioPharma, received a second milestone...
SWK Holdings Corporation to Participate in A.G.P.'s Virtual Healthcare Symposium
DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black, will participate in A.G.P.'s Virtual Healthcare Symposium on Thursday, November...
Stanley Black & Decker (SWK) Set to Announce Quarterly Earnings on Tuesday
Stanley Black & Decker (NYSE:SWK) is set to post its quarterly earnings results before the market opens on Tuesday, October 27th. Analysts expect Stanley Black & Decker to post earnings of $2.53 per share for the quarter. Individual that are...
What to Expect for Stanley Black & Decker's (SWK) Q1 Earnings?
Stanley Black & Decker's (SWK) first-quarter earnings results are likely to reflect the adverse impacts of the coronavirus outbreak. External woes (forex woes, tariffs and commodity inflation) might have hurt too.
Source: https://incomestatements.info
Category: Stock Reports